Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.
Enveda Biosciences
Series C in 2024
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.
Credo AI is a company focused on enabling enterprises to responsibly develop, adopt, and utilize artificial intelligence at scale. Founded in 2020, it offers a sophisticated AI governance platform that automates oversight and risk management associated with AI technologies. This platform ensures continuous regulatory compliance with emerging global standards, including the EU AI Act and guidelines from NIST and ISO. By providing tools to measure, monitor, and manage risks linked to AI implementations, Credo AI helps businesses build customer trust, differentiate their offerings, and effectively manage potential challenges. The company has garnered recognition for its innovation, being listed among the CBInsights AI 100 and named a Technology Pioneer by the World Economic Forum, among other accolades.
Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.
Formation Bio
Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Enveda Biosciences
Series B in 2024
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Astra, Inc., established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.
HumanX focuses on AI serves as a catalyst for enterprises to identify realistic solutions in the rapidly changing AI field.
Founded in 2024, Reken is an AI & cybersecurity company based in San Francisco. It specializes in developing innovative AI platforms and products designed to safeguard against emerging threats such as deepfake social engineering and automated fraud.
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.
Charlie
Debt Financing in 2023
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.
Aibidia, founded in 2018, offers a digital transfer‑pricing platform that connects multinational enterprises across their entire group. The end‑to‑end solution centralises data, automates compliance, and provides actionable insights, allowing firms to design and implement tax strategies that align with global business objectives. With more than 5,000 legal entities on its platform and a client base that collectively generates around €7 billion in revenue, Aibidia helps the world’s largest companies streamline cross‑border operations and improve decision‑making.
Enveda Biosciences
Series B in 2023
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Yendo is a company that offers accounting software tailored for small and medium-sized businesses. As a cloud-based application, Yendo allows users to access its features anytime and anywhere with an internet connection. The software enables users to efficiently manage invoicing, purchases, expenses, and payments, as well as track financial performance through profit and loss statements, balance sheets, and customizable reports. Based in Ireland, Yendo serves a substantial customer base in both the United Kingdom and the United States. Additionally, Yendo provides a credit card platform that offers asset-backed credit products, allowing consumers to leverage the equity in their vehicles or homes for significantly higher credit limits at competitive interest rates. This offering enables users to obtain credit without the need for traditional FICO score checks.
Fable Food Co is a company that specializes in plant-based meat alternatives, primarily utilizing shiitake mushrooms to replicate the taste and texture of traditional meat. The organization focuses on creating minimally processed, clean label products made from all-natural ingredients, catering to the growing demand for healthier and sustainable food options. Fable's offerings are widely available in major Australian grocery chains such as Harris Farm Markets, Coles, and Woolworths, as well as through meal delivery services like Marley Spoon and Dinnerly. Additionally, its products can be found on various restaurant menus across Australia, Singapore, and the UK, making them accessible to a diverse range of consumers seeking vegan substitutes for meat dishes.
Enveda Biosciences
Series B in 2022
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Strand Therapeutics
Series A in 2022
Strand Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in genetically programming mRNA to deliver innovative therapies aimed at enhancing patient outcomes. Founded in 2017, the company develops mRNA programming technology that allows for precise control over the location, timing, and intensity of therapeutic protein expression within the body. By employing mRNA-encoded logic circuits, Strand Therapeutics can achieve cell-type specific expression by detecting unique miRNA signatures and modulating protein dosage in response to externally administered small molecules. The company focuses on creating gene therapies powered by synthetic biology, including immunotherapies designed to enable cells to produce target cancer-killing proteins, thereby strengthening the body's immune response against cancer.
Galileo.ai is a technology company specializing in AI application management. It offers a suite of services including development, testing, monitoring, and security for AI applications. The core product is an AI platform designed to enhance machine learning processes by automatically identifying errors and data gaps, thereby improving efficiencies, reducing costs, and mitigating biases across various industries such as healthcare, finance, and insurance.
LatticeFlow
Series A in 2022
LatticeFlow is a developer of system management software focused on enabling organizations to build and deploy artificial intelligence models that are safe, reliable, and trustworthy. The company's software offers a core programming API within a new asynchronous data coordination framework, facilitating the testing and certification of machine learning systems. This approach ensures that AI models function as intended and are prepared for production use. By providing tools that enhance the robustness and transparency of AI applications, LatticeFlow empowers clients to effectively integrate artificial intelligence into their operations.
Astra, Inc., established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.
Oneleet
Venture Round in 2022
Oneleet is a developer of a comprehensive cybersecurity platform aimed at helping businesses prevent cyber attacks. The company offers scalable manual cybersecurity testing as a service, delivered by vetted expert penetration testers. Utilizing artificial intelligence, Oneleet combines automated assessments with expert manual testing, providing a web asset scanner and compliance checker. This integration allows organizations to seamlessly incorporate security testing into their cybersecurity lifecycle, enhancing their overall defense against potential threats.
X1 is a financial services company that offers an innovative credit card designed to enhance the shopping experience. The X1 Card is crafted from stainless steel and features advanced technology that allows for smart credit limits and an attractive rewards program. Cardholders can earn points for every purchase, which can be redeemed for various benefits. The card is backed by Visa Signature, giving users access to over 46 million merchants globally. Co-founded by former Twitter employees Deepak Rao and Siddharth Batra, X1 has attracted notable investors, including PayPal co-founder Max Levchin and others with significant experience in technology and finance. Through its unique offerings, X1 aims to transform traditional credit card usage and improve the way consumers shop and spend.
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
Manifold Bio
Series A in 2022
Manifold Biotechnologies, Inc. is a biotechnology company that specializes in developing platforms for the pharmacological measurement of various therapeutic protein variants. By integrating DNA technologies with machine learning, the company aims to create protein drugs that address challenging diseases. Manifold Bio's innovative approach includes a protein barcoding platform designed to enable multiplexed quantitation of protein therapeutics, thereby generating extensive data that enhances the drug development process. Founded in 2019 and located in Allston, Massachusetts, the company is focused on advancing measurement-driven design in the field of protein therapeutics.
Guild Education
Series F in 2022
Guild Education provides a technology platform that connects working adults with online classes, programs, and degree options, offering personalized advising and retention coaching. The service enables employers to give employees education benefits and tuition reimbursement, helping them advance their careers while the platform supports discovery, learning, and organization of the experience. It bridges the gap between education and employment, delivering a comprehensive learning journey from start to finish.
Flexport, established in 2013, is a San Francisco-based company specializing in global freight forwarding and customs brokerage services. It offers an online platform that simplifies and streamlines international trade for businesses. Flexport's services include customs clearance, freight transportation by ocean, air, and road, along with value-added services such as cargo insurance, warehousing, and trade finance. The company's user-friendly dashboard enables clients to understand, purchase, manage, and track these services in real-time, optimizing their supply chain and logistics operations.
Monarch Money is a subscription-based platform that provides a personal finance program to track expenses. The platform aims to help consumers plan and manage their financial lives and adds all the transactions, across all bank accounts and credit cards, into one list, and creates a budget to understand where the money is going.